Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agents

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.7, Iss.3, 2008-05, pp. : 305-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The risk of QTc prolongation of IV quinine is enhanced by prior administration of artemether/lumefantrine

Inpharma, Vol. 1, Iss. 1362, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Drugs, QTc Interval Prolongation and Final ICH E14 Guideline: An Important Milestone with Challenges Ahead

By Shah Rashmi R.

Drug Safety, Vol. 28, Iss. 11, 2005-01 ,pp. : 1009-1028

Adis International

Access to resources Recommend Favorite

QTc prolongation associated with methadone treatment

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Examination of Baseline Risk Factors for QTc Interval Prolongation in Patients Prescribed Intravenous Haloperidol

By Muzyk Andrew J. Rayfield Amber

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 547-553

Adis International

Access to resources Recommend Favorite

Escitalopram overdose: QTc interval prolongation: case report

Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite